Pancreatic cancer will be diagnosed in more than 46,000 Americans this year and will be responsible for almost 40,000 deaths. Now, researchers claim they have identified a marker in the blood that may indicate early development of the disease, paving the way for an early detection test. The research team, including co-senior author Dr. Brian Wolpin, of the Dana-Farber Cancer Institute in Boston, MA, publish their findings in the journal Nature Medicine. 

READ FULL ARTICLE Curated publisher From Medical News Today